Physician profile
James Levins
NPI 1679920995
$20,558.61
in general payments reported to CMS, 2019-2025
8 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $350 · 2021: $590 · 2022: $13K · 2023: $4,552 · 2024: $604 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,793 · Honoraria: $1,500 · Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,792.87 |
| Honoraria | $1,500.00 |
| Food and Beverage | $1,063.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2022 | |
| Encore Medical, Lp | $7,480.09 | 2022-2024 | Djo Surgical |
| Stryker Corporation | $1,594.36 | 2019-2025 | Aequalis Perform |
| Medical Device Business Services, INC. | $1,152.47 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $144.21 | 2021 | |
| Skeletal Dynamics INC | $117.52 | 2023 | Implate, Align, Geminus |
| Acumed LLC | $39.42 | 2019 | |
| Prodigy Surgical Distribution, INC. | $30.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Levins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.